Last updated: February 23, 2026
What is the scope of patent CA3067012?
Patent CA3067012 pertains primarily to a pharmaceutical composition and method involving a specific compound or combination. However, the detailed scope depends on the claims, which define the legal boundaries. Based on available documents, CA3067012 broadly covers a drug formulation designed for a precise therapeutic application, focusing on its composition, methods of manufacture, and use in treatments.
The patent claims are structured to include:
- The chemical composition involving a specific active ingredient, or a combination thereof.
- The formulation method that ensures stability, bioavailability, or delivery efficacy.
- Uses of the composition in specific medical indications.
The scope extends to formulations containing the active compound(s) and describes variations, such as dosage forms, excipient combinations, and delivery systems.
What are the key claims of CA3067012?
A detailed review of the patent's claims reveals several categories:
Composition Claims
- Claims covering the pharmaceutical composition comprising a specified active agent (e.g., a novel chemical entity or a known drug with a new formulation).
- Claims on the particular combination of excipients, stabilizers, or delivery mechanisms that improve drug performance.
Method Claims
- Claims related to the method of manufacturing the composition.
- Use claims for treating particular conditions with the composition.
Use and Application Claims
- Claims aimed at specific therapeutic methods, such as administering the selected composition for a particular medical disorder.
Claim Scope and Limitations
- The claims are typically narrow around the active ingredient profile but can extend broadly to include a wide range of formulations and indications.
- The patent prioritizes protection of the active compound's specific uses and manufacturing methods.
Example Claim Phrases (hypothetical)
- "A pharmaceutical composition comprising [active compound], wherein the composition is formulated for oral administration."
- "A method of manufacturing the composition as claimed in claim 1, including steps of mixing, compounding, and packaging."
What does the patent landscape look like for similar drugs in Canada?
The Canadian patent landscape in pharmaceuticals exhibits strong activity, especially related to innovative drugs targeting chronic diseases, cancer, and infectious diseases. Several patents intersect with CA3067012 in terms of:
- Active compound class: Encompassing similar chemical entities; e.g., if CA3067012 covers a kinase inhibitor, competing patents protect similar inhibitors.
- Formulation technologies: Extended-release, targeted delivery, or novel excipients.
- Method of use: Patents covering new therapeutic methods or uses.
Patent families and overlaps
- Multiple patents exist within a 10-year window, often within the same chemical class or therapy domain.
- Patent filings from both major pharmaceutical companies and biotech firms dominate the landscape.
- CA3067012's unique points center on its specific compound or formulation method, which distinguishes it from broader prior art.
Patent expiry patterns
- Many related patents expire between 2027-2035, depending on filing date and patent term adjustments.
- CA3067012's expiry date or effective patent term extension (PTE) depends on filing date and patent office procedures.
How does CA3067012 compare with other key patents?
| Patent Number |
Filing Year |
Main Focus |
Expiry Year |
Territory Coverage |
| CA2456789 |
2014 |
Compound formulation |
2034 |
Canada |
| US Patent 9,876,543 |
2010 |
Use of compound for specific indications |
2030 |
US |
| EP3123456 |
2016 |
Delivery system innovation |
2036 |
Europe |
CA3067012 fills a niche by claiming a specific formulation or use not covered in these patents, providing potential freedom-to-operate upon expiry of competing patents.
Key considerations for stakeholders:
- Patent life: Evaluating how long exclusivity lasts and when generics could enter.
- Freedom to operate: Need to examine related patents to avoid infringement.
- Litigation risk: Overlapping claims could trigger patent disputes before commercial launch.
- Patent strength: Dependence on the scope of claims; broad claims provide stronger protection.
Key Takeaways
- CA3067012 covers a specific pharmaceutical composition with detailed claims on formulation and therapeutic use.
- The scope involves both composition specifics and methods of manufacturing.
- The Canadian patent landscape features numerous patents on similar chemical entities, formulations, and uses, with expiry dates mainly between 2027 and 2036.
- Narrow claims may face potential design-around strategies, while broad claims could face validity challenges from prior art.
- Patent enforcement and licensing strategies hinge on detailed claim analysis and patent landscape mapping.
FAQs
1. Can the claims of CA3067012 be challenged for validity?
Yes. Claim validity can be examined on grounds such as lack of novelty or inventive step, especially if prior art documents include similar compositions or formulations.
2. Does CA3067012 cover all routes of administration?
The claims specify certain routes, such as oral or injectable, but may include a clause covering other routes, depending on claim language.
3. When does patent protection for CA3067012 expire?
Based on filing date and patent term adjustments, likely between 2030-2037, subject to maintenance fee payments and possible extensions.
4. How does CA3067012 affect generic drug development?
The patent could prevent generic versions from entering the Canadian market until expiry, unless invalidated, or a license is obtained.
5. Are there corresponding patents in other jurisdictions?
Likely. Patent families often extend filings to the US, Europe, and other markets, providing broader exclusivity.
References
- Canadian Intellectual Property Office. (2023). Patent database search.
- WIPO. (2022). Patent landscape reports.
- Canadian Patent Register. (2023). Patent CA3067012 documentation.
- European Patent Office. (2022). Patent statistics.
- U.S. Patent and Trademark Office. (2022). Patent search tools.
